Michel Lagarde insider trades

Open-market stock purchases and sales by Michel Lagarde, President and CEO at West Pharmaceutical Services Inc, from SEC Form 4 filings since Jan 31, 2012.

Recent trades

DateStockTradeValue
Sep 8, 2026WST West Pharmaceutical Services IncBought (not open market)—
Sep 8, 2026WST West Pharmaceutical Services IncBought (not open market)—
Sep 8, 2026WST West Pharmaceutical Services IncBought (not open market)—
Sep 8, 2026WST West Pharmaceutical Services IncBought (not open market)—
Sep 8, 2026WST West Pharmaceutical Services IncBought (not open market)—
Sep 8, 2026WST West Pharmaceutical Services IncBought (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 28, 2026TMO Thermo Fisher Scientific IncSold (not open market)$187K
Feb 28, 2026TMO Thermo Fisher Scientific IncSold (not open market)$436K
Feb 25, 2026TMO Thermo Fisher Scientific IncBought (not open market)—
Dec 4, 2025TMO Thermo Fisher Scientific IncSold$12.4M
Dec 4, 2025TMO Thermo Fisher Scientific IncBought (not open market)—
Dec 4, 2025TMO Thermo Fisher Scientific IncBought (not open market)—
Dec 3, 2025TMO Thermo Fisher Scientific IncSold$17.2M
Dec 3, 2025TMO Thermo Fisher Scientific IncSold$1.5M
Dec 3, 2025TMO Thermo Fisher Scientific IncBought (not open market)—
Dec 2, 2025TMO Thermo Fisher Scientific IncSold$17.5M
Dec 2, 2025TMO Thermo Fisher Scientific IncBought (not open market)—
Nov 13, 2025TMO Thermo Fisher Scientific IncSold$2.8M
Nov 13, 2025TMO Thermo Fisher Scientific IncBought (not open market)—

Companies traded

  • WST West Pharmaceutical Services Inc: other filings, last Sep 8, 2026
  • VRTX Vertex Pharmaceuticals Inc / MA: other filings, last May 1, 2026
  • TMO Thermo Fisher Scientific Inc: 46 sales, last Feb 28, 2026
  • PTHN Patheon NV: other filings, last Aug 29, 2017
  • PTI Patheon Inc: other filings, last Nov 18, 2013

Get free alerts when Michel Lagarde files a new trade →